What is BioCryst Pharmaceuticals's net margin?

BioCryst Pharmaceuticals (BCRX) reported net margin of -51.7% in Q1 2026.

How has BioCryst Pharmaceuticals's net margin changed year-over-year?

BioCryst Pharmaceuticals's net margin decreased by 386.9% year-over-year, from -10.6% to -51.7%.

What is the long-term trend for BioCryst Pharmaceuticals's net margin?

Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's net margin has grown at a -50.6% compound annual growth rate (CAGR), from -1,026.4% to 30.2%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

BioCryst Pharmaceuticals BCRX Net margin

Net margin at other companies

Ionis PharmaceuticalsIONS

-30.9%-10.5pp

Ultragenyx PharmaceuticalRARE

-90.9%-2.1pp

ANI PharmaceuticalsANIP

10%+8.1pp

AnaptysBio, Inc.ANAB

-49.9%-22.6pp

BridgeBio PharmaBBIO

-125.9%-54.5pp

PVL

Palvella TherapeuticsPVLA

71.7%+40.4pp

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

net income/total revenue=-51.7%

Based on trailing twelve months.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's net margin?: BioCryst Pharmaceuticals (BCRX) reported net margin of -51.7% in Q1 2026.
How has BioCryst Pharmaceuticals's net margin changed year-over-year?: BioCryst Pharmaceuticals's net margin decreased by 386.9% year-over-year, from -10.6% to -51.7%.
What is the long-term trend for BioCryst Pharmaceuticals's net margin?: Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's net margin has grown at a -50.6% compound annual growth rate (CAGR), from -1,026.4% to 30.2%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.